Rest Of World — Total Revenues
Bristol-Myers Squibb Rest Of World — Total Revenues decreased by 8.1% to $11.49B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $11.20B to $11.49B. Over 3 years (FY 2020 to FY 2025), Rest Of World — Total Revenues shows an upward trend with a 25.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful international expansion and growing global demand for the company's therapeutic offerings, while a decrease may signal competitive pressure or regulatory hurdles in foreign markets.
Detailed definition
This metric represents the total net sales generated from all geographic regions outside of the company's primary domest...
Peer comparison
Peers in the pharmaceutical industry typically report geographic revenue splits, allowing for comparison of international market exposure and global commercial execution.
bmy_segment_rest_of_the_world_total_revenuesHistorical Data
| Q2 '21 | Q2 '21 | Q3 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.70B | $1.44B | $11.62B | $1.39B | $11.99B | $1.46B | $11.65B | $1.31B | $11.89B | $11.22B | $11.41B | $11.34B | $11.23B | $10.97B | $11.48B | $11.87B | $12.20B | $11.89B | $12.34B | $11.20B | $12.27B | $12.22B | $12.50B | $11.49B |
| QoQ Change | — | -87.7% | +710.0% | -88.0% | +761.6% | -87.8% | +697.8% | -88.7% | +804.6% | -5.6% | +1.7% | -0.6% | -1.0% | -2.3% | +4.7% | +3.4% | +2.8% | -2.5% | +3.8% | -9.2% | +9.5% | -0.4% | +2.3% | -8.1% |
| YoY Change | — | — | — | — | — | — | — | — | +1.6% | -3.5% | -4.8% | -2.7% | -5.6% | -2.2% | +0.6% | +4.7% | +8.7% | +8.4% | +7.5% | -5.6% | +0.6% | +2.8% | +1.3% | +2.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's rest of world — total revenues?
- Bristol-Myers Squibb (BMY) reported rest of world — total revenues of $11.49B in Q1 2026.
- How has Bristol-Myers Squibb's rest of world — total revenues changed year-over-year?
- Bristol-Myers Squibb's rest of world — total revenues increased by 2.6% year-over-year, from $11.20B to $11.49B.
- What is the long-term trend for Bristol-Myers Squibb's rest of world — total revenues?
- Over 3 years (2020 to 2025), Bristol-Myers Squibb's rest of world — total revenues has grown at a 25.5% compound annual growth rate (CAGR), from $24.40B to $48.19B.
- What does rest of world — total revenues mean?
- The total revenue generated from all countries excluding the company's home market.